Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04824937
Title Telaglenastat + Talazoparib In Prostate Cancer
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Massachusetts General Hospital

prostate adenocarcinoma


Talazoparib + Telaglenastat

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
*Shaded cells indicate that there was no data available from for the field